Health
Clinical trial analysis suggests drug combination may be highly effective in recurrent ovarian cancer
Significant improvement with the use of a combination drug therapy for recurrent ovarian cancer was reported at the annual meeting of the American Society of Clinical Oncology meeting in Chicago. This is the first ovarian cancer study to use a combination of drugs that could be taken orally. The drugs were tested in a phase I combination study followed by a randomized phase 2 trial sponsored by the National Cancer Institute (NCI), part of the National Institutes of Health.
- Read more
- 373 reads
Calcium Supplements Don't Raise Women's Heart Risks, Study Says
- Read more
- 433 reads
Steroids May Not Be Wise Choice for Intensive-Care Patients
- Read more
- 399 reads
Why Youngest, Oldest Marathoners Post Similar Times
- Read more
- 422 reads
Drug May Lower Odds of Early Menopause in Breast Cancer Patients
- Read more
- 413 reads
CDC awards $19.5 million to Prevention Research Centers nationwide
- Read more
- 412 reads
Scientists See Environmental Changes to Genes in Kids With Autism
- Read more
- 450 reads
Heart Risks Depend on Which Blood Pressure Number Is High: Study
- Read more
- 384 reads
Measles cases in the United States reach 20-year high
- Read more
- 459 reads
U.S. Teens' Cardiorespiratory Fitness Has Dropped in Last Decade: Report
- Read more
- 439 reads
Human Rights
Fostering a More Humane World: The 28th Eurasian Economic Summi
Conscience, Hope, and Action: Keys to Global Peace and Sustainability
Ringing FOWPAL’s Peace Bell for the World:Nobel Peace Prize Laureates’ Visions and Actions
Protecting the World’s Cultural Diversity for a Sustainable Future
Puppet Show I International Friendship Day 2020